BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3368337)

  • 1. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
    Schuemichen C; Krause T; Umbach G; Wolff T
    Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and biodistribution of technetium-99m-MD32P during rat tibial bone repair.
    Schwartz Z; Shani J; Soskolne WA; Touma H; Amir D; Sela J
    J Nucl Med; 1993 Jan; 34(1):104-8. PubMed ID: 8418249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of 99mTc-DPD and 99mTc-MDP on experimentally-induced osteoarthritis in the stifle joint of the dog.
    Lee JY; Lee WG; Kim JH; Kang SS; Bae CS; Koong SS; Choi SH
    In Vivo; 2005; 19(4):781-5. PubMed ID: 15999549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents.
    Vorne M; Vähätalo S; Lantto T
    Eur J Nucl Med; 1983; 8(9):395-7. PubMed ID: 6226527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and localization of 99mTc-methylene diphosphonate in mouse osteosarcoma.
    Nakashima H; Ochi H; Yasui N; Hamada H; Ono K
    Eur J Nucl Med; 1982; 7(12):531-5. PubMed ID: 6218993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A technique to evaluate bone healing in non-human primates using sequential 99mTc-methylene diphosphonate scintigraphy.
    Dormehl IC; Mennen U; Goosen DJ
    Nuklearmedizin; 1982 Jun; 21(3):105-9. PubMed ID: 6215626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy.
    Mageed M; Dyab S; Swagemakers JH; Gerlach K
    Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
    Lantto T; Vorne M; Mokka R; Vähätalo S
    Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for the assessment of local bone uptake of 99mTc-methylene-diphosphonate.
    Vattimo A; Martini G
    J Nucl Med Allied Sci; 1984; 28(1):23-6. PubMed ID: 6207279
    [No Abstract]   [Full Text] [Related]  

  • 17. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
    Holland ME; Bugaj J; Heineman WR; Deutsch E
    Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scintigraphy of sacroiliac joints. A comparison of 99mTc-DPD and 99mTc-MDP.
    Lantto T
    Eur J Nucl Med; 1990; 16(8-10):677-81. PubMed ID: 2143475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG; Allen DR; Smith FD
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
    Ghiron J; Volkert WA; Garlich J; Holmes RA
    Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.